Investment Memorandum · Preview
For informational purposes only. Not investment advice.
Cintas Corporation
CTAS
May 23, 2026
Cintas Corporation (NASDAQ: CTAS) is the #1 US uniform rental and facility services provider with ~31% market share, operating weekly route-based recurring services across Uniform Rental & Facility Services (~77% of revenue), First Aid & Safety (~12%), and All Other/Fire Protection/Direct Sale (~11%). FY2026 guidance: revenue ~$10.5B, EPS ~$4.89. Route-density business model creates structural operating leverage (each additional route adds 60%+ incremental margin). Pending $5.5B UniFirst acquisition; FTC HSR waiting period expires June 11, 2026. If approved, combined entity reaches ~45-48% US market share with $375M annual synergies. Dividend Aristocrat with 42 consecutive dividend increases.
▲ Bull Case
- ◆FTC approves UniFirst without conditions: Deal closes H2 2026; synergies $375M run-rate by FY2030; EPS $7.30 FY2028 at 38-40x multiple → $277-292 (+59-68%)
- ◆Synergies exceed $375M target ($450M+): G&K acquisition precedent suggests management targets are conservative; multiple expansion drives +75-90% upside
- ◆Multiple re-rating to category leader premium: 45%+ market share at scale; route density advantage compounds; multiple to 42-45x → +80-100%
▼ Bear Case
- ◆FTC blocks deal outright: Standalone path continues; stock recovers to $190-200 within 6 months (+9-15%, still positive)
- ◆FTC issues Second Request: Deal delayed 12-18 months; integration timeline pushed; stock holds near $174 for 6-9 months (-5% to +3%)
- ◆Severe (deal blocked + recession): EPS compresses to $4.50; multiple to 30x → $135 → -22% (modest worst case)
“Bulls: Wide-moat compounder + UniFirst transformative + below standalone fair value. Bears: 36-40x P/E is full for industrials; UniFirst integration risk; FTC could surprise. Decision-margin: how much weight to assign FTC risk vs. standalone fundamentals. Market currently double-counting FTC risk + macro risk simultaneously. June 11 catalyst converges the case.”
- ◆FTC HSR waiting period expiry (June 11, 2026) — thesis-defining catalyst; 70% base rate for clearance without Second Request
- ◆UniFirst shareholder vote (June 11, 2026) — near-certain to approve if FTC approves
- ◆Q4 FY2026 earnings (July 2026) — track organic revenue growth >+7% and EPS >$1.30 (qtr) confirmation
- ◆UniFirst deal close (H2 2026 post-FTC) — integration begins; synergy tracking commences
- ◆43rd dividend increase (October 2026) — Dividend Aristocrat streak confirmation; capital discipline signal
- ◆FTC Second Request issued (20% probability) — HSR waiting period extended 12-18 months; deal timeline pushed; stock stalls
- ◆FTC blocks deal outright (15% probability) — synergy thesis destroyed; multiple compression; stock to $190-200
- ◆Synergies disappoint <$200M (25% probability) — integration challenges revealed; multiple compression; thesis damaged
- ◆Recession compresses demand (15% probability) — ISM PMI <45 signals cyclical weakness; organic growth contracts below 6%
- ◆Multiple compression on rate cycle (25% probability) — sustained 10-yr UST >5.5%; industrial multiple compression
Full Memo Continues
5 more sections, locked
- ●Valuation Range & DCFBase/bull/bear fair-value range, WACC, terminal growth, sensitivity to revenue + margin assumptions.
- ●Risk/Reward AssessmentPosition-sizing framework with explicit upside/downside skew and entry conditions.
- ●Management & Capital AllocationMulti-year capital-allocation track record, incentive alignment, and management readout.
- ●Monitoring FrameworkWhat to watch each quarter — leading indicators and inflection signals tracked by the analyst.
- ●Unresolved QuestionsOpen analyst questions and follow-up research items — the depth signal.
For Agents — $2 per memo
Call the JSON API with a Stripe Shared Payment Token. No account, no signup — just pay and call.
GET /api/v1/research/CTAS/memo Authorization: Bearer spt_...
Fund managers — coverage subscriptions launching soon. See marginofinsight.com.